Jared R Tangney

US Patent:

20200297997, Sep 24, 2020

Filed:

Jun 11, 2020

Appl. No.:

16/899541

Inventors:

- San Diego CA, US
Jared Rylan Tangney - Encinitas CA, US
Thomas Arnold Peyser - Menlo Park CA, US

Assignee:

Biolinq, Inc. - San Diego CA

International Classification:

A61N 1/30
A61N 1/05
A61B 5/1468
A61B 5/05
A61B 5/145
A61M 5/172

Abstract:

A device and method for the coupling of an analyte-selective sensor and an infusion system into a singular body-worn device is disclosed herein. Following the coupling, information and/or power is/are exchanged between the two modalities (analyte-selective sensor and an infusion system) by means of a wireless electromagnetic transmission or an electrical connector. The analyte-selective sensor is configured to penetrate the stratum corneum to access the viable epidermis or dermis and measure the presence of an analyte. The infusion system is configured to penetrate the stratum corneum and deliver a solution-phase therapeutic agent.

US Patent:

20200254240, Aug 13, 2020

Filed:

Mar 20, 2020

Appl. No.:

16/824700

Inventors:

- San Diego CA, US
Jared Rylan Tangney - Encinitas CA, US
Thomas Arnold Peyser - Menlo Park CA, US

Assignee:

Biolinq, Inc. - San Diego CA

International Classification:

A61N 1/30
A61M 5/172
A61B 5/145
A61B 5/05
A61B 5/1468
A61N 1/05

Abstract:

A device and method for the manual delivery of a therapeutic intervention in response to a physiological state of a user is disclosed herein. The device comprises a sensor, an infusion system, and a singular body-worn component. The sensor is configured to penetrate the stratum corneum to access the viable epidermis or dermis and measure the presence of an analyte. The infusion system is configured to deliver a solution-phase therapeutic agent based on an action of the user or a control algorithm.

US Patent:

20200101286, Apr 2, 2020

Filed:

Dec 3, 2019

Appl. No.:

16/701784

Inventors:

- San Diego CA, US
Jared Rylan Tangney - Encinitas CA, US
Thomas Arnold Peyser - Menlo Park CA, US
John Sjolund - San Diego CA, US

Assignee:

Biolinq, Inc. - San Diego CA

International Classification:

A61N 1/30
A61B 5/05
A61B 5/145
A61M 5/172
A61B 5/1468
A61N 1/05

Abstract:

Ketoacidosis is a medical emergency that requires swift intervention to avert life-threatening sequel. A body-worn sensor () configured to measure the levels of a ketone compound circulating in a physiological fluid of a wearer and capable of generating an alert to the wearer if the level of the circulating ketone compound exceeds a pre-defined level or rate of change is disclosed herein. The sensor () preferably includes at least one of an electrochemical sensor, an optical sensor, a galvanic sensor, a voltammetric sensor, an amperometric sensor, a potentiometric sensor, an impedimetric sensor, a resistive sensor, a capacitive sensor, an ultrasonic sensor, a radio-frequency sensor, or a microwave sensor.

US Patent:

20190309433, Oct 10, 2019

Filed:

Oct 5, 2017

Appl. No.:

16/334022

Inventors:

Joshua Windmiller - San Diego CA, US
Jared Tangney - San Diego CA, US
- San Diego CA, US

Assignee:

Biolinq, Inc. - San Diego CA

International Classification:

C25D 9/02
A61B 5/1486
A61B 5/1473
A61B 5/145

Abstract:

A method () for constructing a solid-state reference electrode for use in an analyte-selective intracutaneously- or subcutaneously-implanted electrochemical cell is disclosed herein. The method () includes immersing a metallic electrode in a solution comprising a monomer precursor. The method () also includes applying a fixed or time-varying electrical potential or current to the metallic electrode, thereby serving to simultaneously electro-polymerize the monomer precursor and electro-deposit a conducting polymer, synthesized from the electro-polymerization of the monomer precursor, onto the said metallic electrode surface.